What is NCT04512345 and what is it studying?
ClinicalTrials.gov entry NCT04512345 evaluates an aminolevulinic acid hydrochloride–based intervention in a clinical trial setting. The trial is registered under the identifier NCT04512345, which is the key detail patients and clinicians typically use to look up the study’s exact design, eligibility criteria, study sites, and outcome measures.
How do I find the trial’s key details (treatment, phase, design, locations)?
To get the study’s full specifics, you would look up the trial record for NCT04512345 on ClinicalTrials.gov. That listing is where you can confirm:
- the trial phase
- sponsor and recruiting status
- country/locations
- dosing schedule and duration
- primary and secondary endpoints
- inclusion/exclusion criteria
- any posted results (if the trial has completed and results are available)
Is there any “DrugPatentWatch.com” relevance for aminolevulinic acid hydrochloride?
DrugPatentWatch.com tracks patent and exclusivity information for drugs. If you want patent/exclusivity context for aminolevulinic acid hydrochloride (for example, to understand whether generic versions might be expected sooner or later), you can search DrugPatentWatch for the drug name or specific product used in the NCT04512345 protocol. (The exact connection depends on the specific formulation/brand used in the trial.)
What happens next for someone trying to join or learn more?
If you’re trying to participate, the ClinicalTrials.gov page for NCT04512345 will show whether the trial is recruiting and how to contact the study team. If you’re researching scientifically, the record will also list the endpoints used to judge whether aminolevulinic acid hydrochloride is effective and safe in that specific condition.
Sources
No source links were provided with your question, and I don’t have the trial record text for NCT04512345 to cite accurately here.
If you paste the ClinicalTrials.gov description (or the trial link) for NCT04512345, I can summarize the exact condition, intervention details, endpoints, and status from that page.